Patents for C12P 21 - Preparation of peptides or proteins (112,499)
06/1991
06/23/1991WO1991009946A1 Method of preparation of hirudin
06/23/1991WO1991009945A1 Neutrophil chemoattractants
06/23/1991WO1991009935A1 Matrix with adherently bound cells and process for producing viruses/virus antigens
06/23/1991WO1991009871A1 Hybrid molecules having translocation region and cell-binding region
06/23/1991CA2572802A1 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto
06/23/1991CA2072012A1 Neutrophil chemoattractants
06/23/1991CA2071969A1 Hybrid molecules having translocation region and cell-binding region
06/23/1991CA2070399A1 Polypeptides and dna coding therefor
06/23/1991CA2066442A1 Method of preparation of hirudin
06/22/1991WO1991009968A1 Cd3 specific recombinant antibody
06/22/1991WO1991009965A1 An improved toxin for construction of immunotoxins
06/22/1991WO1991009939A1 Transformed cell lines
06/22/1991CA2071998A1 Transformed cell lines
06/22/1991CA2071946A1 Toxin for construction of immunotoxins
06/21/1991WO1991009127A1 BCRF1 PROTEINS AS INHIBITORS OF INTERFERON-$g(g)
06/20/1991WO1991009126A1 Production of human basic fgf mutein
06/20/1991CA2070989A1 Production of human basic fgf mutein
06/20/1991CA2032675A1 Platelet-derived growth factor b chain analogs and method for homogeneous production thereof
06/19/1991WO1991009129A1 Stable integration of dna in bacterial genomes
06/19/1991EP0433225A1 Process for the production of biologically active protein (e.g. TGF)
06/19/1991EP0433088A1 Monoclonal antibodies reactive with a human atheroma associated antigen
06/19/1991EP0432965A1 Malaria vaccine
06/19/1991EP0432510A1 Process for the preparation of genetic vectors for the nerve growth factor expression in eukaryotic cells
06/19/1991EP0432490A2 Immunostimulant agent
06/19/1991EP0432254A1 NUCLEIC ACID CODING FOR THE HUMAN TESTICULAR ANGIOTENSIN CONVERSION ENZYME (ECA) AND ITS APPLICATIONS, IN PARTICULAR FOR THE $i(IN VITRO) DETECTION OF SAID ENZYME IN THE ORGANISM
06/19/1991EP0254735B1 Thermally stable and ph stable subtilisin analogs and method for production thereof
06/19/1991EP0203967B1 Onco-fetal specific monoclonal antibodies, methods of preparation and use
06/19/1991EP0201540B1 Envelope antigens of lymphadenopathy associated virus and their applications
06/19/1991EP0179872B1 Bispecific antibody determinants
06/19/1991CN1052332A Process for producing des(64,65)-proinsulin
06/19/1991CN1052331A Novel antigens and methods therefor
06/19/1991CA2070676A1 Stable integration of dna in bacterial genomes
06/19/1991CA2032405A1 Organic compounds
06/18/1991US5024947 Containing a basal medium, a lipid, a peptone and a protective agent
06/18/1991US5024946 Human monoclonal antibody to antigen of gastric cancer and B-cell line for producing this antibody, method for preparing this B-cell line and antibody, antigen and method of preparation of this antigen
06/18/1991US5024943 Regulatory region cloning and analysis plasmid for bacillus
06/18/1991US5024941 Genetic engineering
06/18/1991US5024939 Transient expression system for producing recombinant protein
06/18/1991US5024938 Culturing
06/18/1991US5024837 Bacillus thuringiensis with acquired toxin-encoding plasmid; genetic engineering
06/18/1991US5024835 Conjugates of a vinca derivative carrying a detergent chain in the C-3 position
06/18/1991CA1284959C Dna sequence useful for the production and secretion from yeast of peptides and proteins
06/16/1991WO1991009134A1 Biospecific antibody to cancer cell and enzyme with prodrug-activating characteristics
06/16/1991WO1991008774A1 Cytokine antibody for the treatment of sepsis
06/16/1991CA2071872A1 Cytokine antibody for the treatment of sepsis
06/16/1991CA2069439A1 Monoclonal antibodies, their production and use
06/16/1991CA2032359A1 Monoclonal antibodies reactive with a human atheroma associated antigen
06/16/1991CA2031831A1 Production method for foreign protein
06/14/1991CA2071858A1 Hiv-1 env fragment fusion protein
06/13/1991WO1991008505A1 Stereoscope
06/13/1991WO1991008488A1 Trypsin inhibitor (alpha, at) peptide, immunoassay, monoclonal antibody and hybridoma
06/13/1991WO1991008478A2 METHODS OF DETECTING COLLAGEN DEGRADATION $i(IN VIVO)
06/13/1991WO1991008303A1 Antibody against human double-stranded tissue plasminogen activator
06/13/1991WO1991008302A1 Monoclonal antibodies specific for acetyl cholinesterase
06/13/1991WO1991008298A2 Fusion proteins consisting of a ligand binding protein and a stable plasma protein
06/13/1991WO1991008296A1 Cdna of orsv gene
06/13/1991WO1991008291A2 Latency associated peptide and uses therefor
06/13/1991WO1991008231A1 [Ala IL-8]77 AS A LEUKOCYTE ADHESION INHIBITOR
06/13/1991WO1991008229A1 Hirudine polyalkylene glycol conjugates
06/13/1991WO1991008228A1 Leucocyte elastasis and cathepsin g-blocking peptide
06/13/1991WO1991008214A1 Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor
06/13/1991WO1991002062A3 C-erbb-2 external domain: gp75
06/13/1991DE3940527A1 Prodn. of HIV-1 regulatory protein NEF
06/12/1991EP0432134A1 Hybridoma cell lines and monoclonal antibodies
06/12/1991EP0431926A1 Process for producing des(64,65)-proinsulin
06/12/1991EP0431880A1 Mutant fungal strain detection
06/12/1991EP0431679A1 Method of stabilizing recombinant hepatitis B virus surface proteins from yeast
06/12/1991EP0431668A1 Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
06/12/1991EP0431541A2 Toxoplasma gondii antigen, its production and use
06/12/1991EP0431350A1 New polypeptide compound and a process for preparation thereof
06/12/1991EP0431171A1 Monoclonal antibody against c-reactive protein
06/12/1991EP0431125A1 Process for producing human monoclonal antibodies
06/12/1991EP0431069A1 Dna sequences, recombinant dna molecules and processes for producing pi-linked lymphocyte function associated antigen-3
06/12/1991EP0431065A1 A FULL LENGTH cDNA ENCODING A HUMAN LAMININ BINDING PROTEIN
06/12/1991EP0431060A1 Method of catalyzing stereochemical reactions
06/12/1991EP0431042A1 A method of preparing an active human neutrophil chemotactic factor polypeptide.
06/12/1991EP0430999A1 Monoclonal antibody for inhibiting cell infection by hiv viruses
06/12/1991CN1052144A Compounds and methods for treatment and diagnosis of cancer
06/12/1991CN1052141A Neurotrophin-3, neurotrophic factor related to nerve growth and brain derived neurotrophic factor
06/12/1991CA2031763A1 Process for purification of a 69000 dalton antigentic protein from bordetella pertussis
06/09/1991WO1991009133A1 Recovery of bt endotoxin protein from lysed cell mixtures
06/09/1991CA2070649A1 Recovery of bt endotoxin protein from lysed cell mixtures
06/09/1991CA2031468A1 Malaria vaccine
06/08/1991WO1991009125A1 Proteins and nucleic acids
06/08/1991WO1991009118A2 Activatable fibrinolytic and anti-thrombotic proteins
06/08/1991CA2069105A1 Proteins and nucleic acids
06/08/1991CA2031390A1 Process for producing des(64,65)-proinsulin
06/05/1991WO1991007986A1 Method of treating septic shock
06/05/1991EP0430645A2 Vaccines
06/05/1991EP0430270A1 Method for the biological inactivation of nucleic acids
06/05/1991EP0430193A1 Monoclonal antibodies and their use
06/05/1991EP0429816A1 Vaccine composition with non-immunosuppresive T-cell epitope component
06/05/1991EP0429788A2 Fragments of porcine somatotropin and antibodies thereto enhancing porcine somatotropin activity
06/05/1991EP0429628A1 Dna sequences, vectors, and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi
06/05/1991EP0429600A1 Saf polypeptide, gene, promoter and use for expression in streptomyces
06/05/1991EP0429587A1 Process for obtaining a regulation protein (nef) for hiv-1 using the human cell line th4-7-5.
06/05/1991EP0429544A1 Synthetic, anti-complement protein and the gene encoding same
06/05/1991EP0429502A1 O-glycosylated igf-1
06/05/1991EP0429484A1 Porcine polyclonal and monoclonal antibodies
06/05/1991EP0429470A1 Antibody recognition of fragments from cytomegalovirus